Citius Pharmaceuticals, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold CTXR, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
9
Funds holding
$111541
Total value held
Buying
5 added/new · 2 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $42224 | 69850 | -1 | 0.00% |
| 2 | Northern Trust Corp | $37928 | 62742 | +18768 | +42.68% |
| 3 | Ubs Group Ag | $15933 | 26335 | +26335 | NEW BUY |
| 4 | State Street Corp | $14067 | 23271 | — | Held |
| 5 | Barclays Plc | $663 | 1096 | +1096 | NEW BUY |
| 6 | Wells Fargo & Company/Mn | $605 | 1000 | +1000 | NEW BUY |
| 7 | Jpmorgan Chase & Co | $69 | 120 | — | Held |
| 8 | Morgan Stanley | $27 | 44 | -1320 | -96.77% |
| 9 | Amalgamated Financial Corp. | $25 | 13731 | +13731 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.